Name:
Metodesnitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine)
Type:
Opioid
AKA:
N/A
Metodesnitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine) image
Synthetic substance, no natural derivative
IUPAC Logo
Metodesnitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine) image
Metodesnitazene, a synthetic opioid, was developed in the 21st century. It is studied for its potent effects on opioid receptors and represents ongoing research into synthetic opioids. Its potential for misuse and abuse is closely monitored due to public health concerns.
Synthetic Substances Image
Metodesnitazene is a potent synthetic opioid with strong analgesic effects. It causes significant sedation, respiratory depression, and constricted pupils. Short-term use provides effective pain relief, while long-term use may lead to addiction and severe health issues. Overdose risks include severe respiratory depression and potential death. Safe use requires careful dosing and medical supervision. Recent research emphasizes its potency and high risk of overdose.
N/A
N/A
N/A
Metodesnitazene is a potent synthetic opioid, similar to fentanyl. Its cultural significance is linked to the opioid crisis and the challenges associated with managing such potent substances. Media coverage often highlights the dangers of synthetic opioids and their role in overdose deaths. The substance is used recreationally rather than medicinally, contributing to societal concerns about drug regulation, harm reduction, and addiction treatment.
N/A